Successful treatment of an elderly patient with lung squamous cell carcinoma by tislelizumab and chemotherapy: a case report with novel imaging findings

The advent of immunotherapy has transformed the therapeutic landscape for inoperable, locally advanced Non-Small cell lung cancer (NSCLC), particularly for lung squamous cell carcinoma (LUSC) with a predominance of negative driver genes. Based on the results of clinical trials such as KEYNOTE-042 an...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Lufan Xu, Xinxin Ma, Yang Yang, Zhiqiang Ding, Yi Luo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Subjects:	lung squamous cell carcinoma tislelizumab PD-1 inhibitor immunotherapy chemotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1543114/full